These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25725274)

  • 21. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H; Tübler T; Sixt S; Fischer M; Schmiedel R; Schulte KL; Balzer JO; Kieback A; Fiehn E; Wittenberg G; Ali T; Tiefenbacher C; Jahnke T; Steinkamp HJ; Wegscheider K; Treszl A; Ingwersen M; Zeller T
    J Endovasc Ther; 2014 Aug; 21(4):463-71. PubMed ID: 25101571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
    J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a randomized clinical trial of external beam radiation to prevent restenosis after superficial femoral artery stenting.
    Therasse E; Donath D; Elkouri S; Lespérance J; Giroux MF; Oliva VL; Guertin MC; Bouchard L; Perreault P; Gilbert P; Soulez G
    J Vasc Surg; 2016 Jun; 63(6):1531-40. PubMed ID: 27021377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol.
    Soga Y; Iida O; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):541-8. PubMed ID: 21805619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous lower extremity arterial interventions using primary balloon angioplasty versus cryoplasty: a randomized pilot trial.
    Shammas NW; Coiner D; Shammas G; Christensen L; Jerin M
    Cardiovasc Revasc Med; 2012; 13(3):172-6. PubMed ID: 22652314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duplex criteria for in-stent restenosis in the superficial femoral artery.
    Kawarada O; Higashimori A; Noguchi M; Waratani N; Yoshida M; Fujihara M; Yokoi Y; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):E199-205. PubMed ID: 22639187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First clinical experience with the Innova versus the Protege EverFlex self-expanding bare metal stents in superficial femoral artery occlusions.
    Gabrielli R; Rosati MS; Chiappa R; Millarelli M; Marcuccio L; Siani A; Caselli G
    Thorac Cardiovasc Surg; 2015 Mar; 63(2):158-63. PubMed ID: 25602844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
    Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
    Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of circulating transforming growth factor beta, tumor necrosis factor alpha and basic fibroblast growth factor with restenosis after transluminal angioplasty.
    Wildgruber M; Weiss W; Berger H; Wolf O; Eckstein HH; Heider P
    Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):35-43. PubMed ID: 17475518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How should I treat a restenosis after superficial femoral artery stenting?
    Fusaro M; Cassese S; Byrne RA
    EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161
    [No Abstract]   [Full Text] [Related]  

  • 33. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
    Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study.
    Karnabatidis D; Kitrou P; Spiliopoulos S; Katsanos K; Diamantopoulos A; Christeas N; Siablis D
    J Nephrol; 2013; 26(2):389-95. PubMed ID: 22641574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery.
    Lam RC; Shah S; Faries PL; McKinsey JF; Kent KC; Morrissey NJ
    J Vasc Surg; 2007 Dec; 46(6):1155-9. PubMed ID: 18154991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions.
    de Donato G; Bosiers M; Setacci F; Deloose K; Galzerano G; Verbist J; Peeters P; Setacci C
    Ann Vasc Surg; 2015; 29(4):738-50. PubMed ID: 25733220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.